What’s New In Glaucoma?
Paul Petrakos, DO, MS
Justin Schweitzer, OD, FAAO
I. Paul Singh, MD
Sarah H. Van Tassel, MD
New Strategies for Individualizing Treatment in DME
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Vera Bril, MD
Neelam Goyal, MD
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Nicholas J. Silvestri, MD
Diagnostic Advances in gMG: Effective Tools and Techniques
Hans Katzberg, MD
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
Mazen Noureddin, MD, MHSc
What’s New in Glaucoma Topical Therapies?
Evolving Strategies for Sustained-Release Glaucoma Treatments
Effective MIGS for Optimal IOP Control: A Case-Based Approach
What’s New in Glaucoma Therapy?
New Solutions for Optimizing IOP Control: A Case-Based Approach
What’s New in Schlemm’s Canal MIGS?
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.